Injectable · Botulinum Toxin · Skin Quality

Skin Botox

How this page was made

This page was written with AI assistance and reviewed against the sources listed under References below. It is general information only, not medical advice. See our full disclaimer for how SHEA creates and reviews treatment information.

What it is

“Skin Botox” is an informal name used for techniques that place multiple small amounts of botulinum toxin superficially in the skin. It may also be marketed under names such as micro Botox or intradermal Botox.

This differs from standard cosmetic Botox treatment, where botulinum toxin is injected into selected muscles to reduce muscle activity. Skin Botox protocols are not standardized, and the botulinum toxin product, dilution, dose, injection depth, and number of injection points can vary.

This intradermal cosmetic use should also be distinguished from the approved indications of the individual botulinum toxin product being used. Ask the clinic which product and protocol they use.

Why people consider it

They are interested in possible changes in skin texture
They are considering treatment for the appearance of enlarged pores or oily skin
They are looking into a superficial botulinum toxin technique rather than standard muscle-targeted Botox

What the experience is like

Intradermal botulinum toxin techniques use multiple small injections across the treatment area. The exact injection pattern, dilution, dose, and product vary between published studies and clinical protocols.

Temporary effects at the injection sites can occur after treatment. Because protocols differ, the expected timing and duration of any cosmetic changes should be discussed with the clinic using the specific product and technique being offered.

Limitations & considerations

The published studies use different botulinum toxin products, doses, dilutions, injection techniques, and outcome measurements, which makes their results difficult to apply to every Skin Botox protocol
Evidence for effects on sebum production and pore appearance is inconsistent between small studies
The available evidence comes from relatively small studies, so findings should not be treated as establishing predictable results for individual patients
Intradermal cosmetic use should not be assumed to have the same regulatory indications or evidence as approved uses of the botulinum toxin product being injected
Contraindications and precautions depend partly on the specific botulinum toxin product used. These can include hypersensitivity to the product or its ingredients, infection at the proposed injection site, and increased risk of clinically significant effects in people with certain neuromuscular disorders
Pregnancy and breastfeeding should be discussed with the treating clinician because safety information depends on the specific botulinum toxin product and available human data are limited

Evidence note

Published evidence for intradermal botulinum toxin remains limited and includes studies using different products and treatment protocols. Small controlled studies have reported findings involving skin texture, sebum production, and pore appearance, but the results are not consistent across studies.

For example, a 2017 split-face randomized pilot study involving 10 participants reported improvement in skin texture after intradermal botulinum toxin but did not find significant reductions in pore size or sebum production. A separate split-face controlled study involving 20 participants with enlarged pores and seborrhea reported greater improvement in sebum and pore scores on the botulinum toxin-treated side than on the saline-treated side.

A 2024 systematic review and meta-analysis included 10 studies with 153 participants. The included studies varied in design and treatment protocol, and trial sequential analysis found that the required information size was not reached for the evaluated outcomes. Larger and more consistent studies are therefore needed before the findings can be considered reliable across Skin Botox treatments generally.

References

Peer-reviewed literature and product safety information.

1. Rahman E, Rao P, Philipp-Dormston W, et al. Intradermal Botulinum Toxin A on Skin Quality and Facial Rejuvenation: A Systematic Review and Meta-analysis. Plastic and Reconstructive Surgery – Global Open, 2024;12(8):e6084.

Peer-reviewed · Systematic review & meta-analysis · 10 studies, n=153

2. Sapra P, Demay S, Sapra S, et al. A single-blind, split-face, randomized, pilot study comparing the effects of intradermal and intramuscular injection of two commercially available botulinum toxin A formulas to reduce signs of facial aging. Journal of Clinical and Aesthetic Dermatology, 2017;10(2):34–44.

Peer-reviewed · Split-face randomized pilot study · n=10

3. Sayed KS, Hegazy R, Gawdat HI, et al. The efficacy of intradermal injections of botulinum toxin in the management of enlarged facial pores and seborrhea: a split face-controlled study. Journal of Dermatological Treatment, 2021;32(7):771–777.

Peer-reviewed · Split-face controlled pilot study · n=20 · No reported COI

4. Current prescribing information for the specific botulinum toxin product used — contraindications, warnings, pregnancy information, and product-specific precautions.

Regulatory · Product-specific safety information